ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted August 30, 2024

Root Bioscience Warned for CBD Claims

On August 30, 2024, the FDA issued a warning letter to Root Bioscience Brands, LLC dba Naternal following a review of the company's websites, which found statements made about the company's products, including CBD Oils Move CBD+CBG Oil, Rest CBD+CBN Oil, Nurture Broad Spectrum Gummies, and Ease Full Spectrum Gummies, to be drug claims.

(See ConsumerLab’s Review of CBD Oils, Softgels, Gummies, Creams & Salves for tests of related products.)

For example, the company’s CBD Oils were promoted with statements such as, “CBD oil has been shown to reduce the nature of PTSD attacks,” and its CBD products promoted with statements such as, “We are starting to understand how CBD may be a game-changer for people with autism to help ease their anxiety, calm their stimming, and reduce any severe behaviors.”

(See ConsumerLab’s answer to the questions What are the best supplements for depression and anxiety? and Which supplements have been shown to be helpful for autism?)

In addition, Root Bioscience’s Naternal Hemp Extract Oil for Pets was promoted to treat conditions such as anxiety, arthritis, and Lyme’s disease.

For more information, use the link below.

Root Bioscience Brands, LLC dba Naternal

See Related Warnings:

Seller of Vision Supplements Warned by FDA

Seller of Omega-3, Ginkgo, Vision Supplements & More Warned for Drug Claims

Seller of Vision Supplements Warned for Drug Claims

Seller of Vision Supplements Warned for Manufacturing Violations, Drug Claims